Richard A Meier
CIK 1227305 · President & CFO · last filed 2026-10-07
Richard A Meier is a President & CFO who has filed 88 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ARAY, was dated Oct 7, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.0M across reported positions. 43 SEC filings were submitted jointly with BIOMARIN PHARMACEUTICAL INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BMRN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
105 DIGITAL DRIVE
NOVATO, CA 94949
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAY | Director | — | $3.79 | — | $0 | 1 | 2026-10-07 |
| BMRN | Director | 127,426 | $57.16 | $7.28M | -$2.72M | 39 | 2025-05-22 |
| Rockley Photonics Holdings Ltd (RKLY.WS) Delisted | President & CFO | — | $0.04 | — | $0 | 1 | 2022-10-21 |
| Intersect ENT, Inc. (XENT) Delisted | EVP & Chief Financial Officer | 106,366 | $28.24 | $3.00M | $164.5K | 8 | 2022-05-16 |
| ACCENDRA HEALTH INC/VA/ (OMI) Delisted | EVP, Chief Financial Officer | 127,158 | $2.80 | $356.2K | $87.1K | 13 | 2018-02-12 |
| STAA | Director | 18,300 | $24.25 | $443.9K | -$60.2K | 10 | 2016-05-23 |
| TFX | Exec. Vice Pres. and CFO | 33,589 | $155.51 | $5.22M | $315.5K | 5 | 2012-02-29 |
Recent Filings
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-07 | ARAY | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | BMRN | Grant (A) | +6,650 | $0 | EDGAR |
| 2024-06-04 | BMRN | Mixed | +1,149 | -$51 | EDGAR |
| 2024-05-23 | BMRN | Grant (A) | +7,080 | $0 | EDGAR |
| 2024-01-23 | BMRN | Gift (G) | −3,000 | $0 | EDGAR |
| 2023-05-24 | BMRN | Grant (A) | +4,190 | $0 | EDGAR |
| 2023-05-17 | BMRN | Mixed | +2,363 | -$63 | EDGAR |
| 2022-10-21 | Rockley Photonics Holdings Ltd (RKLY.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | BMRN | Grant (A) | +4,980 | $0 | EDGAR |
| 2022-05-16 | Intersect ENT, Inc. (XENT) Delisted | U | −163,596 | -$4.62M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.